Frederick Frank, CFA (born May 31, 1932, Salt Lake City, Utah) is an investment banker with more than 50 years of experience on Wall Street. He is considered the first investment banker to have specialized in the areas of biotechnology, pharmaceuticals, and health care services. As of 2014, Frank became a founder and chair of EVOLUTION Life Science Partners. He previously served as vice chairman of Lehman Brothers (where he worked for over 40 years), Barclays Capital, and the Peter J. Solomon Company. He is credited as lead underwriter for over 125 IPOs and as a negotiator in over 75 mergers and acquisitions. Frank was chosen as one of the top 100 contributors to biotechnology in 2005.